Glioblastoma: A Multidisciplinary Approach to Its Pathophysiology, Treatment, and Innovative Therapeutic Strategies

Area of Science:

• Neuro-oncology
• Cancer Biology
• Immunotherapy

Background:

• Glioblastoma (GBM) is the most aggressive primary brain tumor, marked by rapid progression, heterogeneity, and treatment resistance.
• Key pathophysiological mechanisms include neuroinflammation, genetic alterations (EGFR, PDGFRA), tumor microenvironment, microbiome interactions, and sphingolipid/ganglioside dysregulation.

Purpose of the Study:

• To provide an integrated overview of Glioblastoma (GBM) pathophysiology, diagnostics, and therapeutic strategies.
• To highlight current challenges and emerging innovative treatments for GBM.
• To emphasize the need for personalized, multimodal approaches in GBM management.

Main Methods:

• Review of current literature on GBM pathophysiology, diagnosis, and treatment.
• Analysis of established and novel therapeutic modalities, including immunotherapy, nanotechnology, and stem cell-based approaches.
• Evaluation of non-conventional strategies and palliative care.

Main Results:

• GBM's complexity stems from its heterogeneity, inflammation, and unique tumor microenvironment.
• Conventional therapies offer limited survival benefits, necessitating novel treatment strategies.
• Emerging therapies like immunotherapy, nanotechnology, and personalized medicine show promise in overcoming treatment resistance and improving outcomes.

Conclusions:

• GBM requires interdisciplinary research to improve prognosis and patient quality of life.
• Personalized, multimodal treatment strategies are crucial for combating this malignancy.
• Continued investigation into novel therapies is essential for advancing GBM patient care.